Moreover, several other ureido-glutamate-based PSMA-targeted conjugates, including [111In]PSMA-I&T, [18F]PSMA-1007, [225Ac]PSMA-617, and [177Lu]PSMA-I&T are showing very promising response in radiological imaging and therapy of PCa and are in active clinical trials [8,24,32]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.